glp 1 and levothyroxine Glucagon-like peptide-1 receptor agonists risk for cardiovascular events in older adults treated with levothyroxine: a target trial emulation In a patient who has
Description
A randomised controlled trial in 1,897 individuals living with type 2 diabetes compared the impact of three doses of tirzepatide (5mg, 10mg, and 15mg) compared to a once-weekly injection of 1mg semaglutide (Ozempic) on blood sugar levels
Adipose tissue functions as both insulation and an endocrine organ that influences metabolic rate
Approximately 86% of patients with T2DM are overweight or obese, and obesity is considered the greatest risk factor for T2DM (Daousi et al., 2006
GI upset, headache, fatigue, and dizziness
